CRIS Current Research Information System

GANDOLFI, LETIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.277
NA - Nord America 2.090
AS - Asia 1.275
SA - Sud America 86
AF - Africa 84
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.815
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.066
NL - Olanda 701
DE - Germania 545
SG - Singapore 443
CN - Cina 343
GB - Regno Unito 296
VN - Vietnam 253
SE - Svezia 243
IT - Italia 123
HK - Hong Kong 96
RU - Federazione Russa 85
BR - Brasile 69
UA - Ucraina 69
IN - India 66
FR - Francia 60
IE - Irlanda 45
TG - Togo 31
ZA - Sudafrica 30
EE - Estonia 25
CA - Canada 18
KR - Corea 18
FI - Finlandia 17
JP - Giappone 15
PL - Polonia 12
BE - Belgio 11
CH - Svizzera 10
CI - Costa d'Avorio 10
AR - Argentina 9
HR - Croazia 9
NG - Nigeria 9
BG - Bulgaria 8
TR - Turchia 8
IR - Iran 7
LB - Libano 7
ES - Italia 5
ID - Indonesia 5
JO - Giordania 5
MX - Messico 5
BD - Bangladesh 3
EC - Ecuador 3
LT - Lituania 3
AT - Austria 2
CL - Cile 2
PE - Perù 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 5.815
Salva come PNG Salva come JPEG
Città #
Kerkrade 666
Frankfurt am Main 354
Singapore 285
Southend 257
Fairfield 246
Ashburn 197
Santa Clara 165
Chandler 151
Houston 132
Woodbridge 129
Seattle 112
Ann Arbor 105
Wilmington 97
Hong Kong 94
Cambridge 87
Dong Ket 67
Princeton 62
Beijing 61
Boardman 57
Dublin 45
Kyiv 31
Lomé 31
Nanjing 30
New York 30
Berlin 28
Westminster 27
Padova 26
Hefei 25
Los Angeles 25
Jinan 24
Buffalo 23
Falkenstein 23
Bremen 21
Seoul 18
Bologna 17
Ho Chi Minh City 17
Helsinki 16
Jacksonville 16
Secaucus 14
Dearborn 13
Hanoi 12
San Diego 12
Shenyang 12
Tokyo 12
Toronto 12
Changsha 11
Dallas 11
Hangzhou 11
Hebei 11
Abidjan 10
Brussels 10
Düsseldorf 10
Nanchang 10
Bern 9
Milan 9
Munich 9
Redondo Beach 9
Turin 9
Abeokuta 8
Columbus 8
Guangzhou 8
Jiaxing 8
São Paulo 8
Warsaw 8
Istanbul 7
Shanghai 7
Falls Church 6
Florence 6
Haikou 6
Hyderabad 6
Saint Petersburg 6
San Francisco 6
Tianjin 6
Amman 5
Chicago 5
Falconara Marittima 5
London 5
Monmouth Junction 5
Norwalk 5
Paris 5
Phoenix 5
Redwood City 5
Sofia 5
Taiyuan 5
Taizhou 5
Zhengzhou 5
Bengaluru 4
Lanzhou 4
Wayne 4
Andover 3
Brooklyn 3
Bühl 3
Chengdu 3
Chennai 3
Fuzhou 3
Haiphong 3
Jakarta 3
Lancaster 3
Mumbai 3
Mülheim 3
Totale 4.227
Salva come PNG Salva come JPEG
Nome #
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years 1.449
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. 226
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients 216
Is it really possible to cure hairy cell leukemia patients only with frontline therapy? 207
Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma. 195
High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience 195
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study 187
Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial. 181
Long-term responders after Brentuximab vedotin: Single-center experience on relapsed and refractory hodgkin lymphoma and anaplastic large cell lymphoma patients 179
Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients. 169
Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study 168
Efficacy and safety of biosimilar epoetin alpha in patients with chronic lymphoid neoplasms and chemotherapy-induced anaemia: An observational, retrospective, monocentric analysis 155
Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients 150
Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: A case report and review of the literature 148
The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients 146
Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified. 145
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome. 144
Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma. 143
Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma). 140
Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens. 139
Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma. Leuk Lymphoma. 133
Vemurafenib mucosal side-effect. 130
Short-course R-CHOP followed by (90)Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results 126
Primary ocular adnexal lymphomas: a retrospective study of 25 patients. 122
Hairy cell leukemia: evaluation of the long-term outcome in 121 patients. 122
Multisystemic and Multiresistant Langerhans Cell Histiocytosis: A Case Treated With BRAF Inhibitor 120
Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma. 119
Second primary malignancy in myelofibrosis patients treated with ruxolitinib 105
CAMPYLOBACTER PYLORI IN ABATTOIR WORKERS: IS IT A ZOONOSIS? 29
Detection of helicobacter pylori-like organisms in the stomach of some food-source animals using a monoclonal antibody 27
A possible source of Campylobacter pylori? ELISA testing of abattoir workers 25
Endoscopic retrograde cholangiopancreatography (ERCP) in the elderly 24
Cancer of the gastric stump in Italy, 1979–1986 22
Cancer of the gastric stump in Italy, 1979–1986 20
Detection of helicobacter pylori-like organisms in the stomach of some food-source animals using a monoclonal antibody 19
The source of Campylobacter pylori 19
CAMPYLOBACTER PYLORI IN ABATTOIR WORKERS: IS IT A ZOONOSIS? 18
IS CAMPYLOBACTER PYLORI A ZOONOSIS? 18
The source of Campylobacter pylori 14
Totale 5.894
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.003
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.003
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021340 0 0 0 0 0 26 3 24 50 24 24 189
2021/2022648 103 36 34 67 52 28 19 32 20 31 118 108
2022/2023687 83 110 51 93 43 65 13 45 78 20 38 48
2023/2024211 30 28 13 34 15 31 26 3 4 12 7 8
2024/2025838 22 76 33 55 206 28 105 16 10 64 23 200
2025/20261.758 91 116 139 77 242 1.093 0 0 0 0 0 0
Totale 5.894